Aprea Therapeutics, Inc. Common stock — Institutional Ownership
Which tracked institutions hold APRE, and how they changed the position last quarter. Latest holdings as of Jun 30, 2026. Source: SEC 13-F filings.
5
Funds holding
$37855
Total value held
Buying
4 added/new · 1 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Morgan Stanley | $20723 | 25830 | +3500 | +15.67% |
| 2 | Northern Trust Corp | $10996 | 13705 | +13705 | NEW BUY |
| 3 | Blackrock, Inc. | $5755 | 7173 | -1331 | -15.65% |
| 4 | Barclays Plc | $379 | 473 | +473 | NEW BUY |
| 5 | Ubs Group Ag | $2 | 3 | +3 | NEW BUY |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.